An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome. Ebert BL, Galili N, Tamayo P, et al. An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome. PLoS Med. 2008;5(2):e35. doi:10.1371/journal.pmed.0050035 Read more